On what dates did the THC CEO’s share sales occur and how many shares each day?

Saumya Sutaria sold shares on August 24, 2026 and August 25, 2026. On August 24, sales totaled 50,000 shares; on August 25, sales also totaled 50,000 shares, for an aggregate of 100,000 shares of THC common stock.

Does the filing state the CEO’s THC share holdings after these sales?

No post-transaction share balance is reported for these trades. The Form 4 entries for each sale list the shares sold and prices but leave the “shares following transaction” field blank.

Tenet CEO sells 100,000 shares around $275

Q: What insider transaction did THC disclose for CEO Saumya Sutaria?

THC disclosed that CEO Saumya Sutaria sold 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026, at weighted-average prices within ranges of $272.65–$279.14 per share.

Q: What were the reported weighted-average sale prices for the THC CEO’s transactions?

Reported weighted-average prices per share were $278.17 and $278.90 on August 24, 2026, and $273.34, $274.10, and $275.26 on August 25, 2026. Each corresponds to multiple trades within stated price ranges from $272.65 to $279.14.

Q: How many THC shares did the CEO sell at each reported price level?

Saumya Sutaria sold 13,344 shares at $278.17, 36,656 shares at $278.90, 17,220 shares at $273.34, 24,881 shares at $274.10, and 7,899 shares at $275.26. All are weighted-average prices over multiple trades.

Q: Were the THC CEO’s August 2026 sales made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the August 24–25, 2026 sales were made pursuant to a Rule 10b5-1 trading plan.

TENET HEALTHCARE CORP (THC) reported that CEO and director Saumya Sutaria sold a total of 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) reported that CEO and director Saumya Sutaria sold a total of 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026. The sales occurred at weighted-average prices with trade ranges between $272.65 and $279.14 per share, and detailed price breakdowns are available upon request.

Insights

Analyzing...

Insider Trade Summary

Net Seller: 100,000 shares

Net Sell 5 txns

Insider Sutaria Saumya

Role CEO

Sold 100,000 shs ($27.64M)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F2, F4}	17,220	$273.34	$4.71M
Sale	Common Stock ^{F2, F5}	24,881	$274.10	$6.82M
Sale	Common Stock ^{F2, F6}	7,899	$275.26	$2.17M
Sale	Common Stock ^{F1, F2}	13,344	$278.17	$3.71M
Sale	Common Stock ^{F2, F3}	36,656	$278.90	$10.22M

Holdings After Transaction: Common Stock — 433,564 shares (Direct)

Footnotes (6)

F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
F2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
F4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
F5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
F6. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.

Key Figures

Total shares sold: 100,000 shares of Common Stock Shares sold 2026-08-24 at $278.17: 13,344 shares at $278.1700 per share Shares sold 2026-08-24 at $278.90: 36,656 shares at $278.9000 per share +3 more

6 metrics

Total shares sold 100,000 shares of Common Stock Aggregate across all reported sales on 2026-08-24 and 2026-08-25

Shares sold 2026-08-24 at $278.17 13,344 shares at $278.1700 per share Weighted-average sales price; trades ranged from $277.58 to $278.57

Shares sold 2026-08-24 at $278.90 36,656 shares at $278.9000 per share Weighted-average sales price; trades ranged from $278.59 to $279.14

Shares sold 2026-08-25 at $273.34 17,220 shares at $273.3400 per share Weighted-average sales price; trades ranged from $272.65 to $273.64

Shares sold 2026-08-25 at $274.10 24,881 shares at $274.1000 per share Weighted-average sales price; trades ranged from $273.65 to $274.64

Shares sold 2026-08-25 at $275.26 7,899 shares at $275.2600 per share Weighted-average sales price; trades ranged from $274.73 to $275.55

Key Terms

weighted average sales price, open market or private transaction, Common Stock

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate number"

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did THC disclose for CEO Saumya Sutaria?

THC disclosed that CEO Saumya Sutaria sold 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026, at weighted-average prices within ranges of $272.65–$279.14 per share.

What were the reported weighted-average sale prices for the THC CEO’s transactions?

Reported weighted-average prices per share were $278.17 and $278.90 on August 24, 2026, and $273.34, $274.10, and $275.26 on August 25, 2026. Each corresponds to multiple trades within stated price ranges from $272.65 to $279.14.

How many THC shares did the CEO sell at each reported price level?

Saumya Sutaria sold 13,344 shares at $278.17, 36,656 shares at $278.90, 17,220 shares at $273.34, 24,881 shares at $274.10, and 7,899 shares at $275.26. All are weighted-average prices over multiple trades.

Were the THC CEO’s August 2026 sales made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the August 24–25, 2026 sales were made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/26/2026 - 08:00 PM EDT Accepted by SEC EDGAR 08/26/2026 - 08:00 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sutaria Saumya

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

TEXAS

75254

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/24/2026		S		13,344	D	$278.17⁽¹⁾⁽²⁾	520,220	D
Common Stock	08/24/2026		S		36,656	D	$278.9⁽²⁾⁽³⁾	483,564	D
Common Stock	08/25/2026		S		17,220	D	$273.34⁽²⁾⁽⁴⁾	466,344	D
Common Stock	08/25/2026		S		24,881	D	$274.1⁽²⁾⁽⁵⁾	441,463	D
Common Stock	08/25/2026		S		7,899	D	$275.26⁽²⁾⁽⁶⁾	433,564	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.

2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.

4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.

5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.

6. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.

	Chad J. Wiener as Attorney-in-Fact for Saumya Sutaria	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR